[By Bishop Adamu-Chitumu, 23rd April 2026]
The appointment of Dr. Fatima Zuntu as Director-General of the National Biosafety Management Agency (NBMA) has, as expected, stirred debate. Critics have rushed to question her capacity to lead, pointing to her relatively few years of post-graduation experience. Yet this criticism, though loud, is shallow. It fails to appreciate the peculiar strength of her medical background and the qualities that make her uniquely suited to guide the agency at this critical juncture.
Medicine is not a profession that tolerates mediocrity. It is a discipline that demands precision, ethical responsibility, and the ability to make decisions under immense pressure. These qualities are indispensable in biosafety management, where decisions often carry national and global implications. Dr. Zuntu’s training equips her with scientific literacy to grasp complex biosafety issues, ethical grounding to balance innovation with public safety, and decision-making skills honed in contexts where lives are at stake. These attributes are not diminished by the brevity of her post-graduation years; rather, they are amplified by the rigor of her professional journey. To dismiss her readiness on the basis of years alone is to ignore the substance of her preparation.
It is also worth noting that the NBMA has a long tradition of attracting criticism toward its leaders. In fact, it has become something of a ritual. Rufus Ebegba, the pioneer DG, was dismissed as inexperienced. Bello Bwari, who just resigned to pursue a Senatorial ambition in NigerState, was derided for being a lawyer. Now, Zuntu is attacked for being “too young” and “too medical.” One begins to wonder if critics are less concerned with qualifications and more committed to perpetuating a cycle of disapproval. The predictable chorus of condemnation has become satire in itself: no matter who leads NBMA, the antagonists will find a reason to cry foul. If the DG were a scientist, they would say she lacks administrative experience. If he were a lawyer, they would say he lacks scientific grounding. If she were a medical doctor, they would say she is too young. The pattern is so consistent that it has become almost comical.
But satire aside, the real issue lies in the rigidity of the Act establishing NBMA. The Act sets minimum qualifications for the DG role, but perhaps it is time to revisit these clauses. Rigid criteria risk excluding passionate, vibrant leaders who, despite limited years of experience, bring fresh energy and vision. Leadership is not always about the length of one’s résumé; it is often about the quality of one’s perspective, the courage to innovate, and the ability to inspire. Dr. Zuntu represents a new generation of leadership—one capable of pushing NBMA to global standards while prioritizing workers’ welfare, capacity building, and international collaboration. Her appointment is not a deviation from the norm but an opportunity to redefine leadership in biosafety.
Those who argue that she lacks the capacity to perform should consider the broader context. Nigeria’s regulatory agencies have often struggled not because their leaders were too young or too inexperienced, but because they were too entrenched in old ways of thinking, embracing archaic bureaucratic structures. Fresh leadership, particularly from fields as demanding as medicine, offers the possibility of breaking that cycle. Dr. Zuntu’s medical background gives her a unique vantage point: she understands the intersection of science, ethics, and public health in ways that few others can. In an era where biosafety is increasingly tied to global health security, this perspective is invaluable.
Moreover, leadership is not a solitary endeavor. A DG does not operate in isolation but works with a team of experts, administrators, and policymakers. The role of the DG is to provide vision, direction, and accountability. Experience matters, but so does the ability to galvanize a team, to set priorities, and to communicate effectively with stakeholders. These are qualities that Dr. Zuntu has demonstrated in her career, and they are qualities that will serve NBMA well.
The critics, of course, will continue their ritual. They always do. But perhaps it is time for the public to see through the satire of endless condemnation. If every DG is condemned, then perhaps the problem lies not with the individuals but with the system and expectations. Nigeria must decide whether it wants leaders who fit rigid criteria on paper or leaders who bring passion, expertise, and vision to the table. The former may satisfy the letter of the law, but the latter is what will drive progress.
In the end, Dr. Zuntu’s appointment should be embraced as an opportunity. It is a chance to inject fresh energy into NBMA, to push the agency toward global standards, and to prioritize the welfare of its workers. Rather than clinging to outdated notions of qualification, Nigeria should embrace leaders who combine professional expertise with the drive to innovate. If the Act excludes such leaders, then perhaps the Act itself should be revisited. For now, the focus should be on supporting Dr. Zuntu as she takes on the challenge of leading NBMA into a new era.
